HUP0102002A2 - Biológiailag aktív készítmény és eljárás az előállítására - Google Patents

Biológiailag aktív készítmény és eljárás az előállítására

Info

Publication number
HUP0102002A2
HUP0102002A2 HU0102002A HUP0102002A HUP0102002A2 HU P0102002 A2 HUP0102002 A2 HU P0102002A2 HU 0102002 A HU0102002 A HU 0102002A HU P0102002 A HUP0102002 A HU P0102002A HU P0102002 A2 HUP0102002 A2 HU P0102002A2
Authority
HU
Hungary
Prior art keywords
biologically active
carrier
preparation
active ingredient
active composition
Prior art date
Application number
HU0102002A
Other languages
English (en)
Inventor
Catharina Benediktsson
Rickard Bryland
Hakan Hagslätt
Ake Lindahl
Original Assignee
Bioglan Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioglan Ab filed Critical Bioglan Ab
Publication of HUP0102002A2 publication Critical patent/HUP0102002A2/hu
Publication of HUP0102002A3 publication Critical patent/HUP0102002A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

A találmány olyan új biológiailag aktív készítményre vonatkozik,amelyből biológiailag aktív hatóanyag szabadul fel; a biológiailagaktív hatóanyag egy hordozóban oldva és/vagy diszpergálva, túltelítettállapotban van jelen; a hordozó egy folyékony és/vagy szilárd, nemkristályos anyagból áll, és a hordozóban biológiailag aktív hatóanyagkicsapódása lényegében vagy teljesen gátolt. A túltelített állapotúkészítményt úgy állítják elő, hogy egy vagy több kiindulásihordozóanyagot olyan kémiai művelet(ek)nek vetnek alá, hogy egy olyanmátrix képződjön, amelyben a biológiailag aktív hatóanyagtelítettségének mértéke nagyobb, mint a kiindulásihordozóanyag(ok)ban; továbbá a biológiailag aktív hatóanyag hozzáadásaa kémiai reakció(k) előtt vagy egy előre meghatározott időpont utántörténik, majd a kapott készítményen ezután hajtják végre a kémiaiművelet(ek)et. Ó
HU0102002A 1998-05-14 1999-05-12 Biologically active composition and process for its preparation HUP0102002A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801705A SE9801705D0 (sv) 1998-05-14 1998-05-14 Biologically active composition
PCT/SE1999/000824 WO1999058109A1 (en) 1998-05-14 1999-05-12 Biologically active composition

Publications (2)

Publication Number Publication Date
HUP0102002A2 true HUP0102002A2 (hu) 2002-03-28
HUP0102002A3 HUP0102002A3 (en) 2002-12-28

Family

ID=20411319

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102002A HUP0102002A3 (en) 1998-05-14 1999-05-12 Biologically active composition and process for its preparation

Country Status (20)

Country Link
EP (1) EP1077677B1 (hu)
JP (1) JP2002514588A (hu)
KR (1) KR100766998B1 (hu)
CN (1) CN1309554A (hu)
AT (1) ATE252371T1 (hu)
AU (1) AU742921B2 (hu)
CA (1) CA2332110A1 (hu)
DE (2) DE1077677T1 (hu)
DK (1) DK1077677T3 (hu)
ES (1) ES2155049T3 (hu)
GR (1) GR20010300014T1 (hu)
HU (1) HUP0102002A3 (hu)
IL (2) IL139577A0 (hu)
NO (1) NO20005725L (hu)
NZ (1) NZ508074A (hu)
PL (1) PL344221A1 (hu)
SE (1) SE9801705D0 (hu)
TR (1) TR200003588T2 (hu)
WO (1) WO1999058109A1 (hu)
ZA (1) ZA200006476B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064149A1 (en) * 2000-02-29 2001-09-07 Jie Zhang Improved transdermal drug patch
EP1651192A1 (en) * 2003-08-06 2006-05-03 Nirmal Mulye Pharmaceutical composition containing water soluble drug
WO2007147052A2 (en) 2006-06-14 2007-12-21 Dr. Reddy's Laboratories Limited Topical compositions
EP2611852B1 (de) * 2010-08-31 2014-07-30 Basf Se Verzweigte polyester auf basis von zitronensäure sowie deren herstellung und verwendung
JP5964322B2 (ja) * 2011-01-13 2016-08-03 キュー エル ティー インク．ＱＬＴ Ｉｎｃ． 光増感剤の局所送達用医薬組成物及びその使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940701A (en) * 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
SE9502244D0 (sv) * 1995-06-20 1995-06-20 Bioglan Ab A composition and a process for the preparation thereof
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
GB2306885B (en) * 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions

Also Published As

Publication number Publication date
ZA200006476B (en) 2001-06-11
CA2332110A1 (en) 1999-11-18
JP2002514588A (ja) 2002-05-21
ATE252371T1 (de) 2003-11-15
AU4405199A (en) 1999-11-29
EP1077677A1 (en) 2001-02-28
TR200003588T2 (tr) 2001-06-21
CN1309554A (zh) 2001-08-22
PL344221A1 (en) 2001-10-08
NO20005725L (no) 2001-01-11
EP1077677B1 (en) 2003-10-22
IL139577A (en) 2007-07-04
AU742921B2 (en) 2002-01-17
GR20010300014T1 (en) 2001-04-30
NO20005725D0 (no) 2000-11-13
IL139577A0 (en) 2002-02-10
DE69912271T2 (de) 2004-08-26
HUP0102002A3 (en) 2002-12-28
DE69912271D1 (de) 2003-11-27
ES2155049T1 (es) 2001-05-01
KR100766998B1 (ko) 2007-10-15
SE9801705D0 (sv) 1998-05-14
WO1999058109A1 (en) 1999-11-18
DK1077677T3 (da) 2004-02-16
ES2155049T3 (es) 2004-05-16
KR20010052349A (ko) 2001-06-25
DE1077677T1 (de) 2001-09-20
NZ508074A (en) 2003-01-31

Similar Documents

Publication Publication Date Title
CA2474698A1 (en) Polymer-based compositions for sustained release
HUP0201626A2 (hu) Beültethető gélkészítmények és eljárás gyártásukra
DK0717617T3 (da) Mikropartikler indeholdende aktive bestanddele og gas
EP1325766A3 (en) Waste processing method and waste processing apparatus
NO20006645L (no) Ny form av irbesartan, fremgangsmåte for å oppnå den nevnte form og farmasöytiske preparater inneholdende den samme
EP1295590A3 (de) Zweikomponenten-Mittel mit zeitlichem pH-Gradienten und Verfahren zur Behandlung von Haaren
HUP0102002A2 (hu) Biológiailag aktív készítmény és eljárás az előállítására
EP0695184A4 (en) HIV PROTEASE INHIBITORS
HUP0102426A2 (hu) Biológiailag aktív készítmény
HUP0003566A2 (hu) Eljárás dózisforma előállítására, az előállított termék és alkalmazása
CA2259584A1 (en) Plasters containing isosorbide dinitrate
DE69804766T2 (de) Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DK1216043T3 (da) Formulering med forsinket frigivelse indeholdende alfa-liponsyre-(derivater)
DE69810906T2 (de) Optisch aktive 2-amino-tetraline, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die diese enthalten und die nützlich sind zur vorbeugung und behandlung von septischem schock
ATE259784T1 (de) Propanolaminotetraline, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende pharmazeutische zusammensetzungen
ATE95982T1 (de) Gummizusammensetzung aus poroesen perlen, die aktive kaugummi-inhaltsstoffe enthalten und verfahren.
EP0667153A4 (en) PROCESS FOR THE PREPARATION OF A COMPOSITION FOR A SOLID MEDICAMENT.
JPS5231969A (en) Removing method of nitrogen oxide contained in waste gas from fixed bu rning eqipment